+86 18126862446
News

Activity
Notice
Industry

Bladder Scanner Accuracy: What Clinical Studies Actually Show

2026-10-26
38
Guangzhou Sonostar Technologies Co., Limited

A bladder scanner exists to answer one question without inserting a catheter: is there enough urine in there to matter? That is a different standard from “how many millilitres exactly” — and confusing the two is where most buying decisions go wrong. This article summarises what published clinical studies report about bladder scanner accuracy, where it holds up, and where it does not.

1. Why accuracy matters: the trade-off is catheterisation

The reason to measure bladder volume non-invasively is that catheterisation carries real risk.

“The daily risk of development of bacteriuria varies from 3% to 7% when an indwelling urethral catheter remains in situ.”

— Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute-Care Hospitals: 2022 Update. SHEA / IDSA / APIC / CDC Compendium. PMC11287483

The same compendium reports that CAUTI rates in 2020 were 0.754 per 1,000 catheter days for adult inpatient units, that attributable costs range from US$603 to US$1,189 per inpatient case, and — most relevant here — that “of patients who have a urinary catheter placed in the hospital, up to half are placed in patients who may not have an appropriate indication.”

That last figure is the entire business case for a bladder scanner: the harm is not only in the catheter that was needed, but in the one that wasn’t.

2004.jpg

2. How accuracy is actually measured

Nearly all validation studies use the same design: scan the patient, then catheterise and measure. The reference standard is the catheter. Reported metrics differ, and they are not interchangeable:

MetricWhat it tells youWhat it hides
Mean / median difference in mLAverage biasA device can average near zero while being wildly off in individual patients
Limits of agreement (95% LoA)Spread of individual errorOften the most honest number, least often quoted in marketing
Correlation coefficient (r or rho)Whether the device tracks the referenceA high r can coexist with large absolute error
Sensitivity / specificity at a thresholdWhether it correctly triggers catheterisationHighly dependent on which threshold is chosen

Read the limits of agreement, not the correlation.

3. What the studies found

StudyPopulationnFinding
Brouwer et al., 2018Postoperative surgical patients318BVI 9400 overestimated by +17.5% (95% CI +8.8 to +26.3%). Neither device met the predefined ±5% limit
Zheng et al., 2023Postpartum, vaginal delivery70Median difference 42.7 mL; scanner underestimated in 82.9% of cases; accuracy deteriorated at BMI ≥ 30 (P = 0.001)
Mulder et al., 2019Postpartum, vaginal delivery407Median 380 mL vs 375 mL by catheter; mean difference -12.9 mL; Spearman rho = 0.82. Concluded the device “measures PVRV precisely and reliably after vaginal delivery and should be preferred over catheterization”
Salimans et al., 2019Postpartum, 1 week after delivery25Mean difference 312 mL (95% CI 220–404); specificity only 17.6%, PPV 36% at a 200 mL threshold. Concluded the device was “a non-reliable instrument” in this setting
J Obstet Gynaecol Can, 2005Postoperative urogynaecology127 pairsCorrelation r = 0.70 with catheterisation; authors found “limited value” in this population

Note that Mulder (positive, n = 407) and Salimans (negative, n = 25) studied postpartum patients with different devices and different timing, and reached opposite conclusions. Population and timing matter more than brand.

6220.jpg

4. Where accuracy drops

  • Body habitus. Zheng et al. found accuracy significantly worse at BMI ≥ 30.

  • Postoperative state. The 2005 study found only moderate correlation (r = 0.70) after urogynaecologic surgery, and noted accuracy “might increase with greater experience with the procedure.”

  • Postpartum timing. Salimans et al. found large overestimation one week after delivery, with specificity of 17.6% — meaning many patients would be catheterised unnecessarily.

  • Pelvic anatomy. Cystic pelvic structures can be misidentified as bladder, producing falsely elevated readings (Urology. 2000, report of 3 cases and literature review).

One uncomfortable finding worth quoting in full:

“Pain scores recorded with catheterization (2.9/10) were significantly less than those recorded with bladder scanning (4.2/10) (P < 0.001).”

— The use of an ultrasound bladder scanning device in women undergoing urogynaecologic surgery. J Obstet Gynaecol Can. 2005. PMID 16411009

Patients in that study reported the scan as more uncomfortable than the catheter — a reminder that technique, including probe pressure, is part of the experience, not just the hardware.

5. The threshold matters more than the millilitres

There is no universally accepted definition of postoperative urinary retention, and reported incidence varies largely because thresholds differ:

  • >600 mL with insufficient voiding within 30 min → prevalence 4.8% in 334 general surgical patients (Dreijer B, Møller MH, Bartholdy J. Eur J Anaesthesiol. 2011. PMID 21206278)

  • >500 mL within 30 min → incidence 14.0% in 228 PACU patients (Gil YS, Lee GY, Chung WS. Korean J Anesthesiol. 2006;50(6):674–678)

Same clinical phenomenon, threefold difference in reported rate — driven by the cut-off.

Buyer implication: what matters clinically is whether the device reliably sorts patients above and below your threshold. A scanner with ±40 mL median error is entirely fit for a 500 mL decision. A scanner that overestimates by 17% is not.

6. How to read an accuracy claim

When a manufacturer states an error figure, three questions determine whether it means anything:

  1. Bench or clinical? A phantom-tank result under controlled conditions is not a patient result. Both can be legitimate; they must be labelled.

  2. Absolute or percentage? A “±5%” claim at 500 mL is ±25 mL. The same “±5%” at 50 mL is ±2.5 mL. Ask whether the percentage applies across the full range.

  3. Which population, and what BMI range? Published data show deterioration at higher BMI — a claim that doesn’t state the population is incomplete.

Internal note — delete before publishing. Article 3429 states “BProbe-2 / BProbe-5 … <5% error.” Brouwer 2018 explicitly concluded that neither of the two mainstream bladder scanners met the predefined ±5% limit. Recommended fix: state the figure as “<5% in bench/phantom testing” with the test conditions named, and add the BMI ≥ 30 caveat in both the product page and this article.

A well-formed claim looks like: “Median difference vs. catheterisation of X mL (95% LoA: Y to Z) in a clinical study of N patients; accuracy reduced at BMI ≥ 30.”

7. Checklist: what to ask before you buy

  1. What is the median difference and 95% limits of agreement against catheterisation — not just a correlation coefficient?

  2. Was validation bench/phantom or clinical, and in which population?

  3. How does accuracy behave at BMI ≥ 30?

  4. Is the threshold configurable to match our protocol (e.g. 500 mL vs 600 mL)?

  5. How many repeat scans are needed for a stable reading, and does the device average them?

  6. What is the scan-to-result time, and can a nurse perform it after brief training?

  7. Are images or measurements exportable to the record (jpg/MP4/DICOM)?

  8. Is the software licence included for the life of the device, with no per-scan or per-user fee?

Frequently asked questions

How accurate is a bladder scanner?

Published studies report median differences against catheterisation ranging from about 13 mL to over 300 mL depending on device, population and timing. In a 70-patient postpartum study, the median difference was 42.7 mL — considered suitable for clinical use. Accuracy is consistently worse in patients with higher BMI.

Can a bladder scanner replace catheterisation?

For deciding whether to catheterise, yes in many settings — one 407-patient study concluded the scanner “should be preferred over catheterization” for measuring residual volume after vaginal delivery. It does not replace catheterisation when the bladder needs to be drained.

What bladder volume threshold should trigger catheterisation?

There is no universal standard. Published protocols use 500 mL or 600 mL, sometimes combined with a time-to-void criterion. Use your institution’s protocol.

Why do two studies of the same device disagree?

Population, operator training, timing relative to surgery or delivery, and the chosen threshold all move the result. Compare studies on population first, brand second.


References

  1. Brouwer TA, van den Boogaard C, van Roon EN, Kalkman CJ, Veeger N. Non-invasive bladder volume measurement for the prevention of postoperative urinary retention: validation of two ultrasound devices in a clinical setting. J Clin Monit Comput. 2018. PMC6209055

  2. Zheng VJ, Geynisman-Tan J, Knoll J, Kenton K, Brown O. Accuracy of Bladder Scanner in Measuring Bladder Volumes in Postpartum Women. Female Pelvic Med Reconstr Surg. 2023. doi:10.1097/SPV.0000000000001337

  3. Mulder FEM, van der Velde S, Pol F, et al. Accuracy of postvoid residual volumes after vaginal delivery: a prospective equivalence study… Int Urogynecol J. 2019. doi:10.1007/s00192-018-3700-9

  4. Salimans S, Govaerts J, de Jong N, van Bavel J, Speksnijder L. Three-dimensional bladder ultrasonography with the BladderScan® overestimates post void residual one week after delivery. Eur Urol Open Sci. 2019. doi:10.1016/j.eurox.2019.100030

  5. The use of an ultrasound bladder scanning device in women undergoing urogynaecologic surgery. J Obstet Gynaecol Can. 2005. PMID 16411009

  6. Dreijer B, Møller MH, Bartholdy J. Post-operative urinary retention in a general surgical population. Eur J Anaesthesiol. 2011. doi:10.1097/EJA.0b013e328341ac3b

  7. Gil YS, Lee GY, Chung WS. Postoperative Urinary Retention in Postanesthesia Care Unit Detected by Ultrasound Scanner. Korean J Anesthesiol. 2006;50(6):674–678. doi:10.4097/kjae.2006.50.6.674

  8. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute-Care Hospitals: 2022 Update. SHEA / IDSA / APIC / CDC Compendium. PMC11287483

  9. Cystic pelvic pathology presenting as falsely elevated post-void residual urine measured by portable ultrasound bladder scanning: report of 3 cases and review of the literature. Urology. 2000.

These citations are provided for reader reference. The cited authors, journals and organisations have no relationship with this article, and their inclusion is not an endorsement of any commercial product.

This article summarises published literature for equipment-buying context. It is not medical advice, a clinical protocol, or a diagnostic recommendation. Bladder volume measurement should follow your institution’s protocol and local clinical governance. Verify all specifications and accuracy claims with the manufacturer, and request the underlying validation data before purchase.


ADD:Guangzhou, China.  TEL:+86-20-32382095  PHONE:+86 18126862446  EMAIL:sonostar@sonostar.net  WEBSITE:https://www.sonostarmed.com
    XML MAP  HZSZNET.COM